On March 24, 2022 SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, reported that it will announce fourth quarter and full year 2021 financial results and provide a business update on Tuesday, March 29, 2022 (Press release, Scynexis, MAR 24, 2022, View Source [SID1234610926]). The company will host a conference call and webcast at 8:30 a.m. Eastern Daylight Time on the same day.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A recording of the webcast will be posted on the Company’s website, www.scynexis.com, following the event